ArticleJournal of fluorescence2025
Phosphorus and Nitrogen-Doped Graphene Quantum Dots as an Effective Fluorescence Sensor for Furazolidone Determination in Biological and Pharmaceutical Samples.
Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herein, a cost-effective, efficient, sensitive, and selective fluorescent sensor of graphene quantum dots doped with phosphorus and nitrogen (P, N-GQDs) is fabricated for direct determination of furazolidone in human urine and serum samples. The sensor is constructed via a facile hydrothermal method using urea and triphenylphosphine as nitrogen and phosphorus sources. The synthesized P, N-GQDs have a uniform size of less than 5 nm with high photoluminescence properties. The fluorescence intensity of P, N-GQDs at the wavelength of 447 nm is reduced in the presence of copper ions due to the electrostatic interaction between copper ions and the charged surface of the quantum dots. However, in the presence of furazolidone, the formation of a complex between the drug and the copper ions leads to the retrieval of the fluorescence emission of the P, N-GQDs, which is highly sensitive to furazolidone concentration. Under optimal conditions, the linear range of the calibration curve was 0.05-20 µmol L
Indexed as
Identifiers
40856732What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.